Skip to main content
. 2016 Mar 25;7(17):24664–24676. doi: 10.18632/oncotarget.8369

Table 1. Distribution of non-blast cell subsets in the BM of children with BCP-ALL at diagnosis according to the presence vs. absence of altered immunophenotypes on residual maturing and mature BM neutrophils.

Cell subsets BCP-ALL with normal neutrophil phenotypes BCP-ALL with altered neutrophil phenotypes p-value
% of maturing neutrophils 28
(5–55)
19
(2–64)
p = 0.004
% of monocytes 0.92
(0.15–6.7)
1.04
(< 0.1–15)
ns
% of eosinophils 0.73
(0.07–8.1)
0.81
(< 0.1–5.5)
ns
% of basophils 0.18
(< 0.1–1.6)
0.21
(< 0.1–6.5)
ns
% of NRBC 11.1
(1–32)
9.12
(0.3–67)
ns
% of lymphocytes 37
(20–84)
51
(8.8–92)
p = 0.04
 % of T cells 29
(15–75)
35
(5–75)
ns
 % of NK cells 2.2
(< 0.1–7.9)
2.6
(< 0.1–27)
ns
 % of mature B cells 7.1
(< 0.1–22)
8.8
(< 0.1–39)
p = 0.03
% of CD34+ myeloid precursors 0.3
(< 0.1–1.3)
0.6
(< 0.1–3)
p = 0.03
% of CD34+/MPO+ neutrophil precursors from all CD34+ HPC 8
(< 0.1–100)
< 0.01
(< 0.1–100)
ns
% of CD34+/CD7+ precursors from all CD34+ HPC < 0.01
(< 0.1 – 13)
< 0.01
(< 0.1–88)
ns

Results expressed as median (range). BCP-ALL, B-cell precursor acute lymphoblastic leukemia; BM, bone marrow; NRBC, nucleated red blood cells; HPC, hematopoietic progenitor cells.